HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation.

Abstract
Hydrogen sulfide (H2S) has been shown to have powerful antioxidative and anti-inflammatory properties that can regulate multiple cardiovascular functions. However, its precise role in diabetes-accelerated atherosclerosis remains unclear. We report here that H2S reduced aortic atherosclerotic plaque formation with reduction in superoxide (O2 (-)) generation and the adhesion molecules in streptozotocin (STZ)-induced LDLr(-/-) mice but not in LDLr(-/-)Nrf2(-/-) mice. In vitro, H2S inhibited foam cell formation, decreased O2 (-) generation, and increased nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear translocation and consequently heme oxygenase 1 (HO-1) expression upregulation in high glucose (HG) plus oxidized LDL (ox-LDL)-treated primary peritoneal macrophages from wild-type but not Nrf2(-/-) mice. H2S also decreased O2 (-) and adhesion molecule levels and increased Nrf2 nuclear translocation and HO-1 expression, which were suppressed by Nrf2 knockdown in HG/ox-LDL-treated endothelial cells. H2S increased S-sulfhydration of Keap1, induced Nrf2 dissociation from Keap1, enhanced Nrf2 nuclear translocation, and inhibited O2 (-) generation, which were abrogated after Keap1 mutated at Cys151, but not Cys273, in endothelial cells. Collectively, H2S attenuates diabetes-accelerated atherosclerosis, which may be related to inhibition of oxidative stress via Keap1 sulfhydrylation at Cys151 to activate Nrf2 signaling. This may provide a novel therapeutic target to prevent atherosclerosis in the context of diabetes.
AuthorsLiping Xie, Yue Gu, Mingliang Wen, Shuang Zhao, Wan Wang, Yan Ma, Guoliang Meng, Yi Han, Yuhui Wang, George Liu, Philip K Moore, Xin Wang, Hong Wang, Zhiren Zhang, Ying Yu, Albert Ferro, Zhengrong Huang, Yong Ji
JournalDiabetes (Diabetes) Vol. 65 Issue 10 Pg. 3171-84 (10 2016) ISSN: 1939-327X [Electronic] United States
PMID27335232 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2016 by the American Diabetes Association.
Chemical References
  • GYY 4137
  • Keap1 protein, mouse
  • Kelch-Like ECH-Associated Protein 1
  • Lipoproteins, LDL
  • Membrane Proteins
  • Morpholines
  • NF-E2-Related Factor 2
  • Organothiophosphorus Compounds
  • Receptors, LDL
  • oxidized low density lipoprotein
  • Heme Oxygenase-1
  • Hmox1 protein, mouse
  • Glucose
  • Hydrogen Sulfide
Topics
  • Active Transport, Cell Nucleus (drug effects)
  • Animals
  • Atherosclerosis (blood, drug therapy, physiopathology)
  • Diabetes Mellitus (blood, physiopathology)
  • Female
  • Glucose (pharmacology)
  • Heme Oxygenase-1 (genetics, metabolism)
  • Hydrogen Sulfide (blood, metabolism)
  • Kelch-Like ECH-Associated Protein 1 (metabolism)
  • Lipoproteins, LDL (pharmacology)
  • Macrophages, Peritoneal (drug effects, metabolism)
  • Male
  • Membrane Proteins (genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Morpholines (pharmacology, therapeutic use)
  • NF-E2-Related Factor 2 (deficiency, genetics, metabolism)
  • Organothiophosphorus Compounds (pharmacology, therapeutic use)
  • Protein Binding (drug effects)
  • Receptors, LDL (deficiency, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: